Skip to main content
Gentian Diagnostics ASA logo

Gentian Diagnostics ASA — Investor Relations & Filings

Ticker · GENT ISIN · NO0010748866 LEI · 5967007LIEEXZXHNM861 OL Manufacturing
Filings indexed 466 across all filing types
Latest filing 2026-05-13 Major Shareholding Noti…
Country NO Norway
Listing OL GENT

About Gentian Diagnostics ASA

https://www.gentian.com/

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Recent filings

Filing Released Lang Actions
Flaggemelding Gentian Diagnostics
Major Shareholding Notification Classification · 95% confidence The document is a "flaggemelding" (flagging notification) under the Norwegian Securities Trading Act §4-2, stating that DNB Bank ASA now indirectly controls 13.65% of Gentian Diagnostics’ shares due to acquisition of pledged shares. This is a notification of a significant shareholding change crossing a threshold, matching the Major Shareholding Notification category.
2026-05-13 Norwegian Bokmål
Meldepliktig handel og endring i styret - Attachment: Gentian - PCA attachment Vatne Capital AS.pdf
Director's Dealing Classification · 85% confidence The document is a notification of an indirect disposal of shares by a primary insider (related to a board member), detailing instrument, volume, price, date, and venue. This matches the definition of Director's Dealing (insider trades by executives or directors).
2026-05-13 Norwegian Bokmål
Flaggemelding – Gentian Diagnostics ASA - Attachment: Flaggemelding.pdf
Major Shareholding Notification Classification · 88% confidence The document is a mandatory flagging notification under the Norwegian Securities Trading Act (§ 4-2), reporting that an insider’s indirect holding decreased from 13.65% to 0%, thereby crossing the 10% and 5% thresholds. It provides details on share ownership percentages and transaction dates. This corresponds to a Major Shareholding Notification (MRQ).
2026-05-13 Norwegian Bokmål
Meldepliktig handel og endring i styret
Director's Dealing Classification · 85% confidence The document is a notification under the Market Abuse Regulation (Art. 19) and Norwegian Securities Trading Act, describing a reportable trade by Runar Vatne (a company director) and his consequent exit from the board. It covers an insider share transaction and change in board membership. The primary focus is on the reportable director dealing, fitting the “Director’s Dealing (DIRS)” category.
2026-05-13 Norwegian Bokmål
Flaggemelding – Gentian Diagnostics ASA
Major Shareholding Notification Classification · 95% confidence The document is a ‘Flaggemelding’ under the Norwegian Securities Trading Act §4-2, notifying that a shareholder’s indirect stake has fallen below the 10% and 5% thresholds. It reports a change in significant share ownership levels, which matches the definition for a Major Shareholding Notification (MRQ).
2026-05-13 Norwegian Bokmål
Board resignation
Board/Management Information Classification · 92% confidence The document is a brief stock exchange announcement stating that a board member (Mr. Runar Vatne) will resign effective immediately. It announces a change in the company’s board of directors, aligning exactly with the definition for Board/Management Information (MANG).
2026-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.